RxDoctor Payments Data

Charles Wright, MD

Otolaryngology · Nashville, TNNPI 1013064831

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Sanofi at 24.2% of the total.

$3,056in general payments, 2019–2025

Across 115 payments — averaging $26.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$740
  • Regeneron Healthcare Solutions, Inc.$575
  • Stryker$552
  • GSK$289
  • Integra Lifesciences Corporation$179
  • Optinose US, Inc.$124
  • plus $598 from 17 others

What the payments were for

  • Food & beverage$3,056100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,056 in reported general payments places this provider in the 70th percentile of 191 otolaryngology providers in Tennessee.

See all otolaryngology providers in Tennessee

Medicare billing

Part B allowed, 2024
$95,899
Medicare patients
346
Services billed
2,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth32$4,243
Ipratropium Bromide39$1,399
Azelastine Hcl27$1,278
Fluocinolone Acetonide Oil25$957
Mometasone Furoate17$614
Fluticasone Propionate28$561
Tobramycin-DexamethasoneTobramycin/Dexamethasone13$486
Ofloxacin17$485
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$472
Montelukast Sodium23$366
Prednisone42$211
Methylprednisolone28$190
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$186
Doxycycline Hyclate15$111
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$26

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →